Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pregnancy and HIV infection: A european consensus on management.
Coll O, Fiore S, Floridia M, Giaquinto C, Grosch-Wörner I, Guiliano M, Lindgren S, Lyall H, Mandelbrot L, Newell ML, Peckham C, Rudin C, Semprini AE, Taylor G, Thorne C, Tovo PA. Coll O, et al. AIDS. 2002 Jun;16 Suppl 2:S1-18. AIDS. 2002. PMID: 12479261 Review. No abstract available.
Levels and patterns of HIV RNA viral load in untreated pregnant women.
European Collaborative Study; Patel D, Thorne C, Newell ML, Cortina-Borja M. European Collaborative Study, et al. Int J Infect Dis. 2009 Mar;13(2):266-73. doi: 10.1016/j.ijid.2008.07.004. Epub 2008 Oct 16. Int J Infect Dis. 2009. PMID: 18929501 Free article.
Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.
Tariq S, Townsend CL, Cortina-Borja M, Duong T, Elford J, Thorne C, Tookey PA; European Collaborative Study; National Study of HIV in Pregnancy Childhood. Tariq S, et al. J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):326-33. doi: 10.1097/QAI.0b013e31821d34d0. J Acquir Immune Defic Syndr. 2011. PMID: 21499113 Free PMC article.
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
PENPACT-1 (PENTA 9/PACTG 390) Study Team; Babiker A, Castro nee Green H, Compagnucci A, Fiscus S, Giaquinto C, Gibb DM, Harper L, Harrison L, Hughes M, McKinney R, Melvin A, Mofenson L, Saidi Y, Smith ME, Tudor-Williams G, Walker AS. PENPACT-1 (PENTA 9/PACTG 390) Study Team, et al. Lancet Infect Dis. 2011 Apr;11(4):273-83. doi: 10.1016/S1473-3099(10)70313-3. Epub 2011 Jan 31. Lancet Infect Dis. 2011. PMID: 21288774 Free PMC article. Clinical Trial.
57 results